Bristol-Myers Squibb
BMY
BMY
1,409 hedge funds and large institutions have $75.1B invested in Bristol-Myers Squibb in 2014 Q4 according to their latest regulatory filings, with 172 funds opening new positions, 437 increasing their positions, 572 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.53% more ownership
Funds ownership: 71.84% → 72.38% (+0.53%)
24% less repeat investments, than reductions
Existing positions increased: 437 | Existing positions reduced: 572
38% less call options, than puts
Call options by funds: $663M | Put options by funds: $1.07B
Holders
1,409
Holding in Top 10
62
Calls
$663M
Puts
$1.07B
Top Buyers
| 1 | +$446M | |
| 2 | +$349M | |
| 3 | +$299M | |
| 4 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$209M |
| 5 |
O
OppenheimerFunds
New York
|
+$202M |
Top Sellers
| 1 | -$262M | |
| 2 | -$218M | |
| 3 | -$188M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$166M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$162M |